• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

mhopwood@unimelb.edu.au

Credentials


Position
Chair of Psychiatry, Ramsay Health Care
Department of Psychiatry
Education
Doctorate (Research)
University of Melbourne
Masters (Coursework)
Monash University
Bachelors Degree
University of Melbourne
ORCID

0000-0001-6004-4521

Prof Malcolm Hopwood

Chair of Psychiatry, Ramsay Health Care
Department of Psychiatry

264 Scholarly works
15 Projects

HIGHLIGHTS

  • 2026

    Journal article

    The Silexan in the Treatment Of Posttraumatic stress disorder (STOP) trial: protocol for a 12-week randomised controlled trial of adjunctive Silexan for PTSD
    DOI: 10.1186/s12906-026-05312-7
  • 2026

    Journal article

    Approach With Caution: A Pilot Randomised Controlled Trial of Approach Bias Modification for People Undergoing Residential Treatment for Methamphetamine Use Disorder
    DOI: 10.1111/dar.70151
  • 2026

    Journal article

    The Candesartan Adjunctive Depression Trials—CADET
    DOI: 10.1097/JCP.0000000000002156
  • 2025

    Journal article

    The efficacy of adjunctive Garcinia mangostana Linn. (mangosteen) pericarp extract for bipolar depression: 24-week randomised controlled trial
    DOI: 10.1192/bjp.2025.108
  • 2023

    Research grants (international)

    Silexan in the Treatment of Post-Traumatic Stress Disorder (STOP) Trial
  • 2020

    Research contracts (non-grants)

    Pharmacogenetics for Severe Mood Disorders: A Randomised Controlled Trial
  • 2019

    Research grants (ARC, NHMRC, MRFF)

    The Candesartan Adjunctive Bipolar Depression Trial - Cadet
Malcolm Hopwood

Latest Honours,
Awards and Fellowships


2004
Fellow of the Royal Australian and New Zealand College of Psychiatrists (FRANZCP)

RECENT SCHOLARLY WORKS

  • 2025

    Journal article

    Report from the WPA Section on Military Psychiatry
    DOI: 10.1002/wps.21373
  • 2025

    Journal article

    Treatment-resistant depression: An emerging role for esketamine
  • 2025

    Journal article

    160. CHANGES IN QUALITY OF LIFE AND PRODUCTIVITY GAIN AMONG ESKETAMINE RESPONDERS IN A REAL-WORLD STUDY IN AUSTRALIA AND NEW ZEALAND
    DOI: 10.1093/ijnp/pyaf052.122
  • 2025

    Journal article

    Plasma Glial Fibrillary Acidic Protein and Neurofilament Light Are Elevated in Bipolar Depression: Evidence for Neuroprogression and Astrogliosis
    DOI: 10.1111/bdi.70029
  • 2025

    Conference Proceedings

    151. Plasma neurofilament light and glial fibrillary acidic protein are elevated in bipolar disorder: evidence for neuroprogression and astrogliosis
    DOI: 10.1093/ijnp/pyaf052.005
  • 2025

    Journal article

    Apathy and affective symptoms associated with elevated plasma neurofilament light but not p-tau181 in Alzheimer's disease
    DOI: 10.1002/dad2.70151

RECENT PROJECTS

  • 2025

    Research grants (other domestic)

    Towards Better Mental Health Care for Women: The WREN Model
  • 2020

    Research grants (ARC, NHMRC, MRFF)

    The Candesartan Adjunctive Major Depression Trial - CADET: A Double-Blind, Randomised, Placebo-Controlled Trial

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224